Stocks and InvestingStocks and Investing
Tue, March 1, 2022
Mon, February 28, 2022
Sun, February 27, 2022
Fri, February 25, 2022

Puneet Souda Maintained (ABCL) at Buy with Decreased Target to $20 on, Feb 25th, 2022


Published on 2024-10-27 19:50:58 - WOPRAI, Puneet Souda
  Print publication without navigation


Puneet Souda of SVB Leerink, Maintained "AbCellera Biologics Inc." (ABCL) at Buy with Decreased Target from $25 to $20 on, Feb 25th, 2022.

Puneet has made no other calls on ABCL in the last 4 months.



There are 2 other peers that have a rating on ABCL. Out of the 2 peers that are also analyzing ABCL, 0 agree with Puneet's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Puneet


  • Robert Wasserman of "Benchmark" Initiated at Strong Buy and Held Target at $27 on, Tuesday, December 21st, 2021
  • Do Kim of "Piper Sandler" Initiated at Buy and Held Target at $33 on, Friday, November 19th, 2021